Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i> Authors Shotaro Iwamoto (ORCID: https://orcid.org/0000-0002-7710-2449) Hidefumi Hiramatsu (ORCID: https://orcid.org/0000-0003-3136-5670) Jun Matsubayashi (ORCID: https://orcid.org/0000-0003-4104-6833) Shota Kato (ORCID: https://orcid.org/0000-0003-3656-2665) Daisuke Tomizawa (ORCID: https://orcid.org/0000-0003-1520-7007) Norio Shiba (ORCID: https://orcid.org/0000-0003-0392-9221) Yusuke Okuno (ORCID: https://orcid.org/0000-0003-3139-9272) Takao Deguchi (ORCID: https://orcid.org/0000-0001-9932-4299) Kentaro Ohki (ORCID: https://orcid.org/0000-0003-2838-4555) Shin‐ichi Tsujimoto (ORCID: https://orcid.org/0000-0001-5738-4138) Souichi Adachi (ORCID: https://orcid.org/0000-0002-8473-0187) Nobutaka Kiyokawa (ORCID: https://orcid.org/0000-0001-9310-2126) Tatsuya Kamitori (ORCID: https://orcid.org/0009-0003-0472-4663) Motohiro Kato (ORCID: https://orcid.org/0000-0001-5145-1774) Junko Takita (ORCID: https://orcid.org/0000-0002-2452-6520) Shiro Tanaka (ORCID: https://orcid.org/0000-0001-6817-5235) Institutions Shiga University of Medical Science (JP) Shiga University (JP) Mie University (JP) Kyoto University (JP) Nagoya City University (JP) University of Tokyo Hospital (JP) National Center For Child Health and Development (JP) Children's Cancer Center (US) The University of Tokyo (JP) Yokohama City University (JP) Explore the Global Research Space Interactive Map